Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
08/2010
08/12/2010WO2010091265A1 Compounds and methods for treating viral encephalitis
08/12/2010WO2010091262A1 Chimeric newcastle disease viruses and uses thereof
08/12/2010WO2010089339A1 Purification of virus or viral antigens by density gradient ultracentrifugation
08/12/2010WO2010068968A8 Methods and compositions for use of a coccidiosis vaccine
08/12/2010US20100203641 Methods and compositions for expressing negative-sense viral rna in canine cells
08/12/2010US20100203506 Viral variants and methods for detecting same
08/12/2010US20100203147 Viruses for the Treatment of Cellular Proliferative Disorders
08/12/2010US20100203083 Mutated structural protein of a parvovirus
08/12/2010US20100203082 Virus-modified bacteria ghosts
08/12/2010US20100203081 Viral inhibitory nucleotide sequences and vaccines
08/12/2010US20100203073 Hsv-1 epitopes and methods for using same
08/12/2010US20100203019 Podoviriedae bacteriophage having killing activity specific to staphylococcus aureus
08/12/2010CA2750055A1 Novel method
08/11/2010EP2216400A1 Method for manufacturing an active component of a medicine or diagnosis agent in MDCJ cell suspension culture
08/11/2010CN101802179A Two-component genome flavivirus and uses thereof
08/11/2010CN101798568A Separated vibrio parahaemolyticus phage and applications in sterilization and microbe-proofing thereof
08/11/2010CN101797380A Method for preparing hogcholera vaccine
08/11/2010CN101230335B Herpes simplex virus and recombinant virus as well as host cell, and medicinal combination thereof
08/10/2010US7771980 avian cell line infected with orthomyxovirus, paramyxovirus or orthopoxvirus; smallpox, influenza, measles; useful for the mass production of vaccines
08/10/2010US7771979 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
08/10/2010US7771945 Apparatus and method for preparative scale purification of nucleic acids
08/10/2010US7771927 Multiple sclerosis-associated retroviral (MSRV) nucleic acids corresponding to the Env region
08/10/2010US7771729 Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant administration of DNA and ALVAC expression vectors
08/10/2010CA2351589C Plant diacylglycerol acyltransferases
08/10/2010CA2180032C Gene expression control
08/05/2010WO2010088626A2 Electricity generation using phototrophic microbial fuel cells
08/05/2010WO2010088552A1 Immunogenic compositions, vaccines and diagnostics based on canine distemper viruses circulating in north american dogs
08/05/2010WO2010086189A2 Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
08/05/2010US20100197606 Non-proteolysable oligopeptides that inhibit glycoprotein gp41 of the aids virus
08/05/2010US20100196993 Persistently infective sendai virus vector
08/05/2010US20100196992 Intergenic regions as novel sites for insertion of hiv dna sequences in the genome of modified vaccinia virus ankara
08/05/2010US20100196922 Fluorescent metal ion indicators with large stokes shifts
08/05/2010US20100196875 Human erythrovirus
08/05/2010US20100196874 method of drug design
08/05/2010US20100196420 Immunogenic compositions, vaccines and diagnostics based on canine distemper viruses circulating in north american dogs
08/05/2010US20100196419 Enhancement of glycoprotein incorporation into virus-like particles
08/05/2010US20100196336 Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
08/05/2010US20100196324 Multifunctional cytokines
08/05/2010CA2749325A1 Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
08/04/2010EP2213752A1 Recombinant Newcastle disease virus RNA expression systems and vaccines
08/04/2010EP2213726A1 Animal protein-free media for cultivation of cells
08/04/2010EP2213725A1 Animal protein-free media for cultivation of cells
08/04/2010EP2213724A1 Animal protein-free media for cultivation of cells
08/04/2010EP2213300A1 Composition and method for treating cancer using herpes virus
08/04/2010EP1185660B1 Porcine circovirus vaccine in recombinant poxvirus
08/04/2010CN101792744A Recombinant baculovirus expressing Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) immunogen gene and preparation method and application thereof
08/04/2010CN101792743A Recombinant baculovirus expressing porcine circovirus type 2 (PCV-2) immunogen gene and preparation method and application thereof
08/04/2010CN101792742A Recombinant baculovirus expressing IBDV (Infectious Bursal Disease Virus) immunogen gene and preparation method and application thereof
08/04/2010CN101792741A Recombinant baculovirus expressing Japanese Encephalitis Virus (JEV) immunogen gene and preparation method and application thereof
08/04/2010CN101792740A Recombinant baculovirus expressing Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) immunogen gene and preparation method and application thereof
08/04/2010CN101792739A Optimum condition for proliferating Guangxi epidemically representative strains of infectious bursal disease virus (IBDV) in chicken embryo
08/03/2010US7767800 Comprises lymphadenopathy viral sequences for diagnosis of aquired immuno-depressive syndromes
08/03/2010US7767449 Methods using modified vaccinia virus
08/03/2010US7767212 compositions and vaccines comprising at least one Fel d1 antigen or fragment thereof are not only capable of inducing immune responses against Fel d1, and hereby in particular antibody responses, but are, furthermore, capable of desensitizing a patient suffering from cat allergy
08/03/2010US7767210 immunogenic composition, comprising an inactivated whole West Nile virus wherein the West Nile virus is at least one of a strain OK02 having ATCC Accession No. PTA-8079 and a strain OK03 having ATCC Accession No. PTA-8078 and a pharmaceutically acceptable carrier or excipient
08/03/2010US7767209 Modified vaccinia virus Ankara (MVA) mutant and use thereof
08/03/2010CA2409432C Modified morbillivirus v proteins
07/2010
07/29/2010WO2010085660A2 Viral vectors encoding multiple highly homologous non-viral polypeptides and the use of same
07/29/2010WO2010085358A2 Flaviviruses expressing the prm, e, and ns1 proteins of other flaviviruses and uses thereof
07/29/2010US20100190719 Peptides as antimicrobial agents towards campylobacter spp
07/29/2010US20100190234 methods for the formation of disulphide bonds
07/29/2010US20100190233 M13 Bacteriophage as A Chemoaddressable Nanoparticle for Biological and Medical Applications
07/29/2010US20100190232 Functional Mutations In Respiratory Syncytial Virus
07/29/2010US20100189747 Compositions and methods for treating or preventing hiv infection
07/29/2010US20100189746 Adaptation of pitman moore strain of rabies virus to primary chick embryo fibroblast cell cultures
07/29/2010US20100189745 Production of Viral Vaccine
07/29/2010US20100189690 Pseudotyping of retroviral vectors, methods for production and use thereof for targeted gene transfer and high throughput screening
07/28/2010EP2209809A1 Human monoclonal antibodies directed to sialyl lewis c, sialyl tn and n-glycolylneuraminic acid epitopes and a method of analysis of stem cells comprising said epitopes
07/28/2010EP1891210B1 Dengue serotype 2 attenuated strain
07/28/2010CN1651457B Nucleotide sequences of HIV-1 group (or subgroup) o retroviral antigens
07/28/2010CN101790381A Method for producing viral vaccines
07/28/2010CN101787359A Recombinant lentivirus for carrying out targeted induction on osteogenic differentiated cell apoptosis as well as preparation method and application thereof
07/28/2010CN101289656B Long term storage process for mosaic virus of pumpkins
07/27/2010US7763590 Nucleotide sequence complementary to wild-type gene; Rna strand which prevents gene expression
07/27/2010US7763450 Functional influenza virus-like particles (VLPs)
07/27/2010US7763260 Murine calicivirus
07/27/2010US7763259 Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection
07/27/2010US7763258 Used to assess protein binding interactions
07/22/2010WO2010082587A1 Adsorbent for suspension in air
07/22/2010WO2010082385A1 Mouse having human hepatocytes transplanted therein
07/22/2010WO2010052214A3 Novel method
07/22/2010WO2010040023A3 Methods and compositions for protein delivery
07/22/2010WO2010003225A8 Influenza virus-like particles (vlps) comprising hemagglutinin
07/22/2010US20100184663 Methods and Compositions Related to Inhibition of Viral Entry
07/22/2010US20100184605 Plant farnesyltransferases
07/22/2010US20100184192 Avian influenza chimeric vlps
07/22/2010US20100184191 Novel method for generation of rna virus
07/22/2010US20100184190 Influencing viral lipid constituents
07/22/2010US20100184019 Novel Human Virus Causing Severe Acute Respiratory Syndrome (SARS) and Uses Thereof
07/22/2010US20100184016 Methods and compositions in the treatment of porcine circoviral infection
07/22/2010US20100184014 Non-M, non-O HIV-1 strains, fragments and uses
07/22/2010US20100183664 Attenuated recombinant newcastle disease virus and vaccine containing the same
07/22/2010US20100183651 Broadly Representative Antigen Sequences and Method for Selection
07/22/2010US20100183588 Mutated Netrin-4, Fragments Thereof And Their Use As Medicines
07/21/2010EP2208736A2 Endogenous retrovirus up-regulated in prostate cancer
07/21/2010EP2207804A1 Monoclonal antibodies specific to hemagglutinin from influenza virus h5-subtype and uses thereof
07/21/2010EP1161537B2 Non-spreading pestivirus
07/21/2010CN101784655A Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles
07/21/2010CN101781636A Proliferous type recombination oncolytic adenovirus containing 11-type adenovirus cilia protein gene, construction method and application thereof
07/21/2010CN101780278A Bivalent hand-foot-and-mouth disease inactivated vaccine
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 267